INBXNasdaq United States
Market cap
$1.301 B
$88.66 +3.35%
Close of 7 Aug 2026
Revenue
$1.30M
#3482 by revenue
Earnings
-$140.1M
Loss-making
Shares outstanding
14,607,036
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Inhibrx Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.